These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9539788)

  • 1. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
    Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
    Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
    Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
    Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
    J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.
    Zeng H; Sanyal S; Mukhopadhyay D
    J Biol Chem; 2001 Aug; 276(35):32714-9. PubMed ID: 11435426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.
    Tao Q; Backer MV; Backer JM; Terman BI
    J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
    Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
    J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
    Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
    J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
    Gingras D; Lamy S; Béliveau R
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
    J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
    Dougher M; Terman BI
    Oncogene; 1999 Feb; 18(8):1619-27. PubMed ID: 10102632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells.
    Chen JH; Wang XC; Kan M; Sato JD
    Cell Biol Int; 2001; 25(3):257-60. PubMed ID: 11352499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.
    Kim YM; Hwang S; Kim YM; Pyun BJ; Kim TY; Lee ST; Gho YS; Kwon YG
    J Biol Chem; 2002 Aug; 277(31):27872-9. PubMed ID: 12029087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability.
    Kondo S; Matsumoto T; Yokoyama Y; Ohmori I; Suzuki H
    Biochim Biophys Acta; 1995 Feb; 1243(2):195-202. PubMed ID: 7533000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.
    Fairbrother WJ; Christinger HW; Cochran AG; Fuh G; Keenan CJ; Quan C; Shriver SK; Tom JY; Wells JA; Cunningham BC
    Biochemistry; 1998 Dec; 37(51):17754-64. PubMed ID: 9922141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.